APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $474,511 | +44920.0% | 12,474 | +7.8% | 0.03% | -52.4% |
| Q2 2023 | $1,054 | +40.9% | 11,575 | +2.0% | 0.06% | +37.0% |
| Q1 2023 | $748 | +53.6% | 11,346 | +20.5% | 0.05% | +53.3% |
| Q4 2022 | $487 | -100.0% | 9,418 | -83.7% | 0.03% | -88.4% |
| Q3 2022 | $3,942,000 | +43.0% | 57,717 | -5.3% | 0.26% | +51.5% |
| Q2 2022 | $2,757,000 | -54.5% | 60,977 | -48.9% | 0.17% | -46.9% |
| Q1 2022 | $6,063,000 | -6.2% | 119,322 | -12.8% | 0.32% | +1.3% |
| Q4 2021 | $6,466,000 | +7.7% | 136,760 | -24.9% | 0.32% | +1.0% |
| Q3 2021 | $6,005,000 | -49.6% | 182,205 | -3.4% | 0.32% | -50.5% |
| Q2 2021 | $11,923,000 | +59.6% | 188,656 | +8.4% | 0.64% | +41.6% |
| Q1 2021 | $7,469,000 | – | 174,056 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |